Allergy & Asthma Network hosted its annual advocacy day on Capitol Hill on May 7, 2025. More than 100 attended in person and many…
The new FDA Commissioner is tasked with leading an agency entrusted with improving food safety and the approval of vital medical treatments.
EPA’s effort to roll back established air quality protections raises serious concerns about the impact on people with respiratory diseases, including asthma.
October 2024 marks the 20th anniversary of landmark federal legislation allowing students to self-carry and use their quick-relief asthma inhaler at school.
Allergy & Asthma Network applauds Delaware for a new law that requires insurance companies to cover early introduction of food allergens.
Elijah’s law mandates guidelines for childcare providers, ensuring safer environments for children with food allergies.
Allergy & Asthma Network joins 25 other patient advocacy and public health groups to protect clean air standards.
The new EPA standards for vehicles will help protect respiratory health and address climate change.
At our 27th annual advocacy day, we connected with members of Congress and supported people living with asthma, allergies, and related conditions.
EPA’s new standards would reduce methane and other harmful air pollution that impacts climate change.
Hear from asthma specialists and state asthma programs on how to improve access to asthma management and treatment.
The Family Asthma Act, named after the late Congressman from Baltimore, would strength the nation’s public health response to asthma.
Allergy & Asthma Network works to help Americans with asthma, allergies and related conditions at the federal, state and local level. Making sure the patient’s voice is heard in legislation and policy issues is an important part of the Network’s advocacy work. Advocates play a crucial role in raising awareness, educating policymakers and the general public, removing barriers to care and making issues widely known to make medical care and treatment more accessible and effective. One key advocacy initiative is to ensure people living with asthma disparities have equal access to high-quality and affordable care. The COVID-19 pandemic has brought new healthcare issues to the forefront, such as H.R. 7647, the “Preserving Patient Savings on Drug Costs Act.” This legislation delays increasing medication costs for a year after the pandemic ends, putting a cap on out-of-pocket costs, and allow drug-sharing coupons to count towards deductibles. It highlights the importance of all patients to get the medicine they need during the COVID-19 health crisis.
10304 Eaton Place, Suite 100
Fairfax, VA 22030
Phone: 800-878-4403
Quick Links
Quick Links